JP2018538267A5 - - Google Patents

Download PDF

Info

Publication number
JP2018538267A5
JP2018538267A5 JP2018526144A JP2018526144A JP2018538267A5 JP 2018538267 A5 JP2018538267 A5 JP 2018538267A5 JP 2018526144 A JP2018526144 A JP 2018526144A JP 2018526144 A JP2018526144 A JP 2018526144A JP 2018538267 A5 JP2018538267 A5 JP 2018538267A5
Authority
JP
Japan
Prior art keywords
aqueous solution
acid
bilastin
concentration
organic carboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018526144A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018538267A (ja
Filing date
Publication date
Priority claimed from EP15382574.0A external-priority patent/EP3170816A1/en
Application filed filed Critical
Publication of JP2018538267A publication Critical patent/JP2018538267A/ja
Publication of JP2018538267A5 publication Critical patent/JP2018538267A5/ja
Withdrawn legal-status Critical Current

Links

JP2018526144A 2015-11-20 2016-11-18 ベンズイミダゾール化合物の過飽和組成物 Withdrawn JP2018538267A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15382574.0 2015-11-20
EP15382574.0A EP3170816A1 (en) 2015-11-20 2015-11-20 Supersaturated compositions of benzimidazole compounds
PCT/EP2016/078154 WO2017085265A1 (en) 2015-11-20 2016-11-18 Supersaturated compositions of benzimidazole compounds

Publications (2)

Publication Number Publication Date
JP2018538267A JP2018538267A (ja) 2018-12-27
JP2018538267A5 true JP2018538267A5 (cg-RX-API-DMAC7.html) 2019-07-11

Family

ID=54707730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018526144A Withdrawn JP2018538267A (ja) 2015-11-20 2016-11-18 ベンズイミダゾール化合物の過飽和組成物

Country Status (6)

Country Link
US (1) US20180344854A1 (cg-RX-API-DMAC7.html)
EP (2) EP3170816A1 (cg-RX-API-DMAC7.html)
JP (1) JP2018538267A (cg-RX-API-DMAC7.html)
ES (1) ES2778434T3 (cg-RX-API-DMAC7.html)
PT (1) PT3377479T (cg-RX-API-DMAC7.html)
WO (1) WO2017085265A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3681475T3 (da) * 2017-10-16 2021-02-01 Faes Farma Sa Vandige sammensætninger omfattende bilastin og mometason
CN116211795B (zh) * 2022-12-26 2025-09-26 深圳市贝美药业有限公司 一种比拉斯汀口服液体制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US818454A (en) * 1904-04-06 1906-04-24 Andrew Krus Lathe-dog.
ES2048109B1 (es) 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
ES2124167B1 (es) 1996-06-04 1999-09-16 Espanola Prod Quimicos Nuevos derivados del bencimidazol con actividad antihistaminica.
EP1505066B1 (en) * 2002-04-19 2006-12-06 Faes Farma, S.A. Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic
US20080132419A1 (en) * 2006-10-04 2008-06-05 Nair Rodriguez-Hornedo Dissolution and precipitation of cocrystals with ionizable components
CN103351380B (zh) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 一种制备比拉斯汀的方法

Similar Documents

Publication Publication Date Title
JP6843103B2 (ja) グルタルイミド誘導体、その使用、それに基づいた医薬組成物及びグルタルイミド誘導体を製造するための方法
HRP20231201T1 (hr) Kristalni metiltionij klorid hidrati
JP2018516883A5 (cg-RX-API-DMAC7.html)
JP2017524733A5 (cg-RX-API-DMAC7.html)
JP2016503010A5 (cg-RX-API-DMAC7.html)
NO20051726L (no) Pyrimidinonderivaer som terapeutiske midler ovenfor akutte og kroniske inflammasjons-, iskemiske og remodeleringsprosesser
FI3406609T3 (fi) Bisyklisiä atsayhdisteitä muskariinireseptorin agonisteina
NO20082264L (no) Histamin-3 reseptorantagonister
JP2016530210A (ja) ヘテロ環式ビニルオートタキシン阻害剤化合物
RU2009133254A (ru) Соли 668
TW200529854A (en) Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
JP2017519015A5 (cg-RX-API-DMAC7.html)
JP2018538267A5 (cg-RX-API-DMAC7.html)
JP2018520188A (ja) 呼吸器合胞体ウイルス(rsv)感染症の処置のためのn−[(3−アミノ−3−オキセタニル)メチル]−2−(2,3−ジヒドロ−1,1−ジオキシド−1,4−ベンゾチアゼピン−4(5h)−イル)−6−メチル−4−キナゾリンアミンの結晶形
JP2018509426A5 (cg-RX-API-DMAC7.html)
NO20064659L (no) Nye kvarterniserte quinuklidin-estere
JP2005529084A5 (cg-RX-API-DMAC7.html)
MX385650B (es) Derivado de bisamida de acido dicarboxilico como agente que estimula regeneracion de tejidos y recuperacion de funcion tisular disminuida.
CN103923168A (zh) 一种阿加曲班一水合物的制备方法
AR073848A1 (es) Utilizacion de la 4-(3-(hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos del sueno. composicion farmaceutica.
JP2014506577A5 (cg-RX-API-DMAC7.html)
TR201901449T4 (tr) Yeni bifenil türevi ve bunun hazırlanmasına yönelik yöntem.
JP2016523943A5 (cg-RX-API-DMAC7.html)
CN105560252A (zh) 一种宠物耳道疾病的复方液体滴剂
JP2010540440A5 (cg-RX-API-DMAC7.html)